Upgrade to SI Premium - Free Trial

Anthera Pharma's (ANTH) Blisibimod Receives FDA Orphan Drug Status

August 9, 2017 6:25 AM
Anthera Pharma' (NASDAQ: ANTH) Blisibimod received FDA orphan drug status for treatment of patients with immunoglobulin A ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles